Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Atzpodien

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Leukemia & Lymphoma|February 1, 1994
Newer options for treating drug-resistant (MDR+) cancer cells using photoradiation therapyS C Gulati, R M Lemoli, T Igarashi, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Elevated plasma levels of interleukin-1 receptor antagonist are associated with decreased cellular BCL-2 oncoprotein expression in B-chronic lymphocytic leukemiaS Duensing, A Nasarek, J Grosse, et al.
Archives of Dermatological Research|October 29, 1999
Tumor markers in peripheral blood of patients with malignant melanoma: multimarker RT-PCR versus a luminoimmunometric assay for S-100C Berking, E M Schlüpen, A Schrader, et al.
Progress in Clinical and Biological Research|January 1, 1990
Photoradiation methods for purging autologous bone marrow graftsS Gulati, J Atzpodien, R M Lemoli, et al.
Lancet (London, England)|June 23, 1990
Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignanciesJ Atzpodien, A Körfer, C R Franks, et al.
Cancer Biotherapy|January 1, 1995
In vivo distribution of integrins in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasisG Anastassiou, S Duensing, G Steinhoff, et al.
Cancer Biotherapy|January 1, 1994
Induction of cytokines and cytotoxicity against tumor cells by Newcastle disease virusU Zorn, I Dallmann, J Grosse, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1987
Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) culturesJ Atzpodien, D Wisniewski, S Gulati, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Lack of therapeutic efficacy of tamoxifen in advanced renal cell carcinomaA Schomburg, H Kirchner, M Fenner, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 10, 2002
Interleukin-12 inhibits apoptosis in chronic lymphatic leukemia (CLL) B cellsS Schuhknecht, S Duensing, I Dallmann, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Leukemia & Lymphoma|February 1, 1994
Newer options for treating drug-resistant (MDR+) cancer cells using photoradiation therapyS C Gulati, R M Lemoli, T Igarashi, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Elevated plasma levels of interleukin-1 receptor antagonist are associated with decreased cellular BCL-2 oncoprotein expression in B-chronic lymphocytic leukemiaS Duensing, A Nasarek, J Grosse, et al.
Archives of Dermatological Research|October 29, 1999
Tumor markers in peripheral blood of patients with malignant melanoma: multimarker RT-PCR versus a luminoimmunometric assay for S-100C Berking, E M Schlüpen, A Schrader, et al.
Progress in Clinical and Biological Research|January 1, 1990
Photoradiation methods for purging autologous bone marrow graftsS Gulati, J Atzpodien, R M Lemoli, et al.
Lancet (London, England)|June 23, 1990
Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignanciesJ Atzpodien, A Körfer, C R Franks, et al.
Cancer Biotherapy|January 1, 1995
In vivo distribution of integrins in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasisG Anastassiou, S Duensing, G Steinhoff, et al.
Cancer Biotherapy|January 1, 1994
Induction of cytokines and cytotoxicity against tumor cells by Newcastle disease virusU Zorn, I Dallmann, J Grosse, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1987
Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) culturesJ Atzpodien, D Wisniewski, S Gulati, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Lack of therapeutic efficacy of tamoxifen in advanced renal cell carcinomaA Schomburg, H Kirchner, M Fenner, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 10, 2002
Interleukin-12 inhibits apoptosis in chronic lymphatic leukemia (CLL) B cellsS Schuhknecht, S Duensing, I Dallmann, et al.
Pageof 12